ROMJ Rubicon Organics

Rubicon Organics Announces the Results of Annual General and Special Meeting and Provides Corporate Leadership Update

Rubicon Organics Announces the Results of Annual General and Special Meeting and Provides Corporate Leadership Update

VANCOUVER, British Columbia, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, is pleased to announce the voting results from its Annual General and Special Meeting of the shareholders (the “Meeting”), held on December 13, 2022.

A total of 42,831,695 shares were represented in person or by proxy at the meeting, constituting approximately 76.38% of the Company’s total issued and outstanding Common Shares as of the record date.

Results of Annual General and Special Meeting

The following matters put forward before shareholders for consideration and approval as set out in Rubicon Organics’ management information circular dated November 8, 2022 (the “Circular”) were approved by the shareholders:

  • Setting the number of directors of the Company at five;
  • Electing Jesse McConnell, Margaret Brodie, John Pigott, David Donnan, and Melanie Ramsey as directors of the Company for the ensuing year until the next annual meeting of the Company; and
  • Appointing PricewaterhouseCoopers LLP as the Company’s auditors for the ensuing year with the Company’s directors authorized to fix their remuneration.

An updated corporate presentation presented at the Meeting is available for viewing on Rubicon Organics’ website at .

Leadership Announcements – Interim CEO & Board of Directors (the “Board”) Succession Planning

In August 2022, Jesse McConnell, Co-Founder and Chief Executive Officer (“CEO”) of Rubicon announced his resignation as CEO effective December 31, 2022. The Board has appointed Margaret Brodie, current Chief Financial Officer (“CFO”), to act as Interim CEO effective January 1, 2023. The Board continues its search of both internal and external candidates to lead the Company in driving forward its vision to be the “global brand leader in premium organic cannabis”.

Mr. McConnell has also announced his resignation from the Board effective December 13, 2022. The Board is actively searching for three new independent candidates to add to the Board and welcomes suggestions. The Board currently has four members and David Donnan acts as Lead Independent Director. The Board does not intend to appoint a Chair until new independent directors are appointed.

The Board would like to thank Jesse McConnell for his enormous contributions to Rubicon Organics. Mr. McConnell Co-Founded the Company in 2015 and with his passion, resilience and hard work has built Rubicon into Canada’s leading premium and organic cannabis Company. Mr. McConnell’s vision and leadership in the cannabis industry has helped to set the standard for the premium cannabis market.

“Building Rubicon Organics to this point has been a wonderful journey and I am extremely proud of the Company and its people. I’m looking forward to spending more time with my young family and am stepping away from Rubicon Organics with confidence of the team in place and current trajectory of business,” said Jesse McConnell, CEO.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including its flagship super-premium brand Simply Bare™ Organic, its premium flower and hash brand 1964 Supply Co.™, its premium concentrate brand LAB THEORY™, its mainstream brand Homestead Cannabis Supply™ and its topical brand Wildflower™.

The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada.

CONTACT INFORMATION

Margaret Brodie

Chief Financial Officer

Phone: +1 (437) 929-1964

Email:

The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ goal of achieving industry leading profitability are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including the effective date of the resignation of the current CEO, the ability to attract and retain a new CEO and new independent directors, the impact on revenue of new products and brands entering the market, and the timing of achieving Adjusted EBITDA profitability and cash flow positive. Risks and uncertainties associated with the forward looking information in this press release include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing federal, provincial, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits for construction at its facilities in a timely manner; regulatory or political change such as changes in applicable laws and regulations, including bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; Rubicon Organics’ limited operating history and lack of historical profits; reliance on management; the effect of capital market conditions and other factors on capital availability; the Company’s ability to attract and retain skilled staff; competition, including from more established or better financed competitors; the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers; and the effects of the COVID-19 pandemic. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.



EN
14/12/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Rubicon Organics

Nicholas Cortellucci ... (+2)
  • Nicholas Cortellucci
  • CFA

ROMJ: First Harvest at Cascadia; On Time and On Budget

What you need to know: • ROMJ announced that it has completed the first harvest of cannabis at its new Cascadia facility, with the ramp up being on time and on budget. • We believe this strong execution speaks to management’s reputation and operational efficiency, building on its already positive track record. • Flagship-quality cannabis is expected to be reached in mid-2026, and management foresees opportunities to increase capacity further. • This week, Organigram announced the acquisition of ...

 PRESS RELEASE

Rubicon Organics Marks Cascadia Facility Grand Opening with Completion...

Rubicon Organics Marks Cascadia Facility Grand Opening with Completion of First Harvest New facility “Cascadia” increases Rubicon’s production capacity by an estimated 40%, allowing the company to capture more of its unmet demand domestically and for branded international salesHaving executed the facility ramp-up on time and on budget, Cascadia is now fully plantedCascadia’s estimated production capacity is 4,500 kg of premium cannabis annually VANCOUVER, British Columbia, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Comp...

 PRESS RELEASE

Rubicon Organics Announces Grant of RSUs and PSUs

Rubicon Organics Announces Grant of RSUs and PSUs VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon” or the “Company”), is Canada’s leading premium licensed producer focused on cultivating and selling organic certified, premium and super-premium cannabis products, announces that it has granted 1,002,773 restricted share units (“RSUs”) and 1,002,773 performance share units (“PSUs”). RSU Grant The Company has awarded a total of 1,002,773 RSUs under its Omnibus Equity Incentive Plan to selected exe...

Nicholas Cortellucci ... (+2)
  • Nicholas Cortellucci
  • CFA

ROMJ: Lots of Positive Developments; Reiterating Bullish Stance

What you need to know: • Last month, MTL Cannabis (MTLC:CSE) was acquired by Canopy for 11.6x LTM EBITDA, which would value ROMJ at $1.50/share. • There has been steady insider buying of ROMJ with Director Doris Bitz purchasing $31K and Director John Pigott purchasing $48K. • ROMJ closed on a $4M credit facility and received numerous awards at the KIND Awards, including Flower of the Year. • We also provide a preview of Q4 financials, which should be released around late March. There have bee...

Ben Pirie ... (+3)
  • Ben Pirie
  • Nicholas Cortellucci
  • CFA

Q4/25 Recap: All Our Research in One Place!

Q4/25 capped off a strong finish to the year for Atrium Research, as supportive commodity price trends and improving small-cap sentiment continued to drive performance across our coverage universe. Our covered stocks increased 21% on average during Q4/25 and are now up 170% over the past year, materially outperforming the TSX and TSXV, which gained 6% and 45% during the quarter, respectively, and 28% and 61% on a YoY basis. Performance was broad-based, with several names delivering outsized retu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch